spot_imgspot_img

The Gene Technology Bill

spot_img

Don't Miss

Vaccine Adverse Effects

The New Year: Cancer Data Indicates a Turning Point

On the Friday before Christmas, Health New Zealand quietly released the 2023 New Zealand cancer data to a media preoccupied with end of year holiday trivia. Not...

Red Flag: 2023 New Zealand Cancer Data Released by Health NZ—A Record

Executive Summary The 2023 rate of new cancer registrations in New Zealand reached an all time record 29,719 new cancer registrations. This was a rate of 5.69 cancers...

Open Letter to the Directors of Health Insurance Companies

Sent personally to CEOs of Southern Cross, FMG, IAG, UniMed/Accuro, NIB and Partners Life Dear Director  Sometimes information helps us to understand puzzling situations. Business models can be very...

Stay up to date with our official bulletins!

Please fill in your details and we will keep you up to date with the truth!

Genetics

Checking the Facts

Government Policy

spot_imgspot_img

Latest Articles

New Data Is Confirming Increases in All-Cause Deaths Associated With mRNA Covid Vaccination

Yesterday a new paper at an open access platform (OSF) was published about German excess all-cause deaths. This offered confirmatory evidence concerning the excess...

Guy Hatchard PhD Answers Questions From Keith Lynch at Stuff Newspaper

This morning I received an email from Keith Lynch, ‘Science Explainer’ at Stuff newspaper. Apparently Keith intends to write a ‘hit piece’ on me...

Are Unvaccinated People at Serious Risk From Omicron in NZ?

Many people have been asking me about numerous recent articles in mainstream media reporting high risks for unvaccinated people and enhanced protection for the...

Are We Heading to an Unprecedented Era of Health Gains or a Modern Medical Dystopia?

When a serious crime has been committed, the police generally lose no time in their efforts to locate the culprit and bring them to...

A Time for Plain Speaking at WHO

Today the World Health Organisation issued an Interim Statement on COVID-19 vaccines in the context of the circulation of the Omicron SARS-CoV-2 Variant from...

Hot Topics

spot_imgspot_img